Fernando Bittinger
University of Mainz
79 Papers
1.3K Citations
Fernando Bittinger is an academic researcher from University of Mainz. The author has contributed to research in topics: Cell adhesion molecule & Acetylcholine. The author has an hindex of 35, co-authored 79 publications. Previous affiliations of Fernando Bittinger include RWTH Aachen University.
Chat about Author
Papers
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma
Gerd Otto,Sascha Herber,Michael Heise,Ansgar W. Lohse,Christian Mönch,Fernando Bittinger,Maria Hoppe-Lotichius,Marcus Schuchmann,Anja Victor,Michael B. Pitton +9 more
TL;DR: Sustained response to TACE is a better selection criterion for LT than the initial assessment of tumor size or number, according to the multivariate analysis.
412
Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?
Patrick Micke,Andreas Faldum,Tsegay Metz,Kai-Michael Beeh,Fernando Bittinger,Jan-Georg Hengstler,Roland Buhl +6 more
TL;DR: The IASLC staging criteria for SCLC patients have a higher prognostic impact and are therefore preferable in clinical practice and future therapeutic trials.
402
The Non-neuronal Cholinergic System
TL;DR: In this article, the role of non-neuronal acetylcholine sensitive receptors (nicotinic, muscarinic) in the regulation of basic cell functions like gene expression, proliferation, differentiation, cytoskeletal organization, cell-cell contact (tight and gap junctions, desmosomes), locomotion, migration, ciliary activity, electrical activity, secretion and absorption.
232
Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?
TL;DR: A critical appraisal of the clinical and experimental evidence for sepsis‐induced dysregulation of the microcirculation and how knowledge of the underlying cellular and molecular pathology could be used to make therapy more rational and effective is aimed at.
175
•Journal Article
Characterization of c-kit Expression in Small Cell Lung Cancer: Prognostic and Therapeutic Implications
Patrick Micke,Maryam Basrai,Andreas Faldum,Fernando Bittinger,Lars Rönnstrand,Andree Blaukat,Kai Michael Beeh,Franz Oesch,Berthold Fischer,Roland Buhl,Jan G. Hengstler +10 more
TL;DR: c-kit represents a new prognostic factor in SCLC and is of particular clinical relevance in patients with advanced disease and poor response to chemotherapy, given the very limited therapeutic options and unfavorable prognosis of patients.
172